Taisho Pharmaceutical Holdings Co Ltd Sustainability Reports
The company operates as a holding company that manages subsidiaries engaged in the manufacturing, development, and sale of over-the-counter (OTC) drugs, prescription pharmaceuticals, health foods, and cosmetics.
Sector: Manufacturing
Country: Japan
Exchange: Tokyo Stock Exchange
FIGI: BBG0021NMNX2
7 reports from 2015 to 2022
- Taisho Pharmaceutical Holdings Co Ltd 2022 Environmental Report
- Taisho Pharmaceutical Holdings Co Ltd 2022 Annual Report
- Taisho Pharmaceutical Holdings Co Ltd 2021 Environmental Report
- Taisho Pharmaceutical Holdings Co Ltd 2020 Environmental Report
- Taisho Pharmaceutical Holdings Co Ltd 2018 Annual Report